Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Hair loss lowers young men's self-esteem, increasing social anxiety and affecting daily life.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

More research, better treatments, and public education are needed for dermatological conditions in people of African descent.

EFBL offers hidden incisions, faster recovery, and fewer risks, but may raise hairline and cost more.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Dutasteride more effective for hair growth, but has more side effects than finasteride.

Blood vessels and specific genes help turn cartilage into bone when bones heal.

HairMax LaserComb® effectively promotes hair growth and stops hair loss in males with androgenetic alopecia, with no serious side effects.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Finasteride may help some male chronic pelvic pain patients, but more research needed.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

Men who think they are losing hair feel worse about themselves, especially if they are younger.

PRP treatment may increase hair density and reduce hair loss, but more research is needed.

PRP therapy may effectively treat hair loss, but more research needed.

Two-photon microscopy helps observe hair follicle stem cell behaviors in mice.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

STAT5 activation is crucial for starting the hair growth phase.